Lung injury has been front and center as the most dreaded complication of COVID-19, but heart damage is yet another grim outcome.

In use in 96 countries on six continents, a curriculum created by HMS students is educating their peers about the new coronavirus.

HMS scientists have launched a clinical trial to evaluate a rheumatoid arthritis medication as a potential treatment for severe COVID-19.

A new Harvard collaboration aims to revolutionize understanding of the human immune system and accelerate creation of effective vaccines.